These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2482710)

  • 1. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs.
    Hermán F; Magyar K; Chabrier PE; Braquet P; Filep J
    Br J Pharmacol; 1989 Sep; 98(1):38-40. PubMed ID: 2508983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antiaggregatory effect of BM 13.177 on the spontaneous platelet aggregation in anaesthetized beagle dogs.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S90-3. PubMed ID: 3073773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the disaggregating effect of prostacyclin (PGI2) in anaesthetized dogs.
    Hermán F; Hadházy P; Magyar K
    Biomed Biochim Acta; 1984; 43(8-9):S377-80. PubMed ID: 6393972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
    Müller B; Maass B; Stürzebecher S; Skuballa W
    Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostacyclin analogues on platelet aggregation and blood pressure of anaesthetized beagle dogs.
    Hermán F; Hadházy P; Magyar K; Kovács G
    Prog Clin Biol Res; 1987; 242():101-6. PubMed ID: 3313407
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iloprost on salt-sensitive Dahl rats.
    Somova L
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):443-7. PubMed ID: 8577205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets.
    Kobzar G; Mardla V; Järving I; Samel N
    Cell Physiol Biochem; 2001; 11(5):279-84. PubMed ID: 11684817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin.
    Filep JG; Hermán F; Battistini B; Chabrier PE; Braquet P; Sirois P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S216-8. PubMed ID: 1725337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat.
    Stürzebecher S; Haberey M; Müller B; Schillinger E; Schröder G; Skuballa W; Stock G; Vorbrüggen H; Witt W
    Prostaglandins; 1986 Jan; 31(1):95-109. PubMed ID: 3513260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.